BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
CXCL2
,
Angiogenesis
,
Obesity
,
Leukocyte
,
Holistic medicine
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TDP- 43
Summary
General Info
Curated Studies
Most Correlated Studies
Neuroblastoma SH-SY5Y cells with TDP-43 siRNA knockdown or TDP-43 N352S mutation
Knockdown of transactive response DNA-binding protein TDP-43
Neuroblastoma SH-SY5Y cells with siRNA mediated TDP-43 and DAZAP1 knockdown
Cervical cancer HeLaM cells with TDP-43 knockout rescued
Expression Profiling of Caenorabditis elegans tdp-1 loss-of-function mutant
Explore Curated Studies Results
Literature
Most Relevant Literature
Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular sp…
Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-induc…
Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.
Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and re…
Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epige…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic …
Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families
AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Tamoxifen Treatment in Patients With Motor Neuron Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ